Cargando…
Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs
BACKGROUND: People who inject drugs (PWID) are a high-risk group for COVID-19 transmission and serious health consequences. Restrictions imposed in the UK in response to the pandemic led to rapid health and housing service alterations. We aimed to examine PWID experiences of: 1) challenges relating...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289673/ https://www.ncbi.nlm.nih.gov/pubmed/34343945 http://dx.doi.org/10.1016/j.drugpo.2021.103391 |
_version_ | 1783724340012908544 |
---|---|
author | Kesten, Joanna M. Holland, Adam Linton, Myles-Jay Family, Hannah Scott, Jenny Horwood, Jeremy Hickman, Matthew Telfer, Maggie Ayres, Rachel Hussey, Deborah Wilkinson, Jack Hines, Lindsey A. |
author_facet | Kesten, Joanna M. Holland, Adam Linton, Myles-Jay Family, Hannah Scott, Jenny Horwood, Jeremy Hickman, Matthew Telfer, Maggie Ayres, Rachel Hussey, Deborah Wilkinson, Jack Hines, Lindsey A. |
author_sort | Kesten, Joanna M. |
collection | PubMed |
description | BACKGROUND: People who inject drugs (PWID) are a high-risk group for COVID-19 transmission and serious health consequences. Restrictions imposed in the UK in response to the pandemic led to rapid health and housing service alterations. We aimed to examine PWID experiences of: 1) challenges relating to the COVID-19 public health measures; 2) changes to opioid substitution therapy (OST) and harm reduction services; and 3) perceived effects of COVID-19 on drug use patterns and risk behaviour. METHODS: Telephone semi-structured interviews were conducted with 28 PWID in Bristol, Southwest of England. Analysis followed a reflexive thematic analysis. RESULTS: Concern about COVID-19 and adherence to public health guidance varied. Efforts made by services to continue providing support during the pandemic were appreciated and some changes were preferred, such as less frequent OST collection, relaxation of supervised consumption and needle and syringe programmes (NSP) home delivery. However, remote forms of contact were highlighted as less beneficial and more difficult to engage with than in-person contact. Public health guidance advising people to ‘stay home’ led to increased isolation, boredom, and time to ruminate which impacted negatively on mental health. Lockdown restrictions directly impacted on sources of income and routine. Changes in drug use were explained as a consequence of isolation and fewer interactions with peers, problems accessing drugs, reduced drug purity and reduced financial resources. CONCLUSION: This study captures the significant impacts and challenges of the COVID-19 pandemic on the lives of PWID. While rapid adaptations to service delivery to help mitigate the risks of COVID-19 were appreciated and some changes such as relaxation of supervised daily OST consumption were viewed positively, barriers to access need further attention. Going forwards there may be opportunities to harness the positive aspects of some changes to services. |
format | Online Article Text |
id | pubmed-8289673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82896732021-07-20 Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs Kesten, Joanna M. Holland, Adam Linton, Myles-Jay Family, Hannah Scott, Jenny Horwood, Jeremy Hickman, Matthew Telfer, Maggie Ayres, Rachel Hussey, Deborah Wilkinson, Jack Hines, Lindsey A. Int J Drug Policy Research Paper BACKGROUND: People who inject drugs (PWID) are a high-risk group for COVID-19 transmission and serious health consequences. Restrictions imposed in the UK in response to the pandemic led to rapid health and housing service alterations. We aimed to examine PWID experiences of: 1) challenges relating to the COVID-19 public health measures; 2) changes to opioid substitution therapy (OST) and harm reduction services; and 3) perceived effects of COVID-19 on drug use patterns and risk behaviour. METHODS: Telephone semi-structured interviews were conducted with 28 PWID in Bristol, Southwest of England. Analysis followed a reflexive thematic analysis. RESULTS: Concern about COVID-19 and adherence to public health guidance varied. Efforts made by services to continue providing support during the pandemic were appreciated and some changes were preferred, such as less frequent OST collection, relaxation of supervised consumption and needle and syringe programmes (NSP) home delivery. However, remote forms of contact were highlighted as less beneficial and more difficult to engage with than in-person contact. Public health guidance advising people to ‘stay home’ led to increased isolation, boredom, and time to ruminate which impacted negatively on mental health. Lockdown restrictions directly impacted on sources of income and routine. Changes in drug use were explained as a consequence of isolation and fewer interactions with peers, problems accessing drugs, reduced drug purity and reduced financial resources. CONCLUSION: This study captures the significant impacts and challenges of the COVID-19 pandemic on the lives of PWID. While rapid adaptations to service delivery to help mitigate the risks of COVID-19 were appreciated and some changes such as relaxation of supervised daily OST consumption were viewed positively, barriers to access need further attention. Going forwards there may be opportunities to harness the positive aspects of some changes to services. Elsevier 2021-12 /pmc/articles/PMC8289673/ /pubmed/34343945 http://dx.doi.org/10.1016/j.drugpo.2021.103391 Text en © 2021 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Paper Kesten, Joanna M. Holland, Adam Linton, Myles-Jay Family, Hannah Scott, Jenny Horwood, Jeremy Hickman, Matthew Telfer, Maggie Ayres, Rachel Hussey, Deborah Wilkinson, Jack Hines, Lindsey A. Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title | Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title_full | Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title_fullStr | Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title_full_unstemmed | Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title_short | Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs |
title_sort | living under coronavirus and injecting drugs in bristol (lucid-b): a qualitative study of experiences of covid-19 among people who inject drugs |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289673/ https://www.ncbi.nlm.nih.gov/pubmed/34343945 http://dx.doi.org/10.1016/j.drugpo.2021.103391 |
work_keys_str_mv | AT kestenjoannam livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT hollandadam livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT lintonmylesjay livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT familyhannah livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT scottjenny livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT horwoodjeremy livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT hickmanmatthew livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT telfermaggie livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT ayresrachel livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT husseydeborah livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT wilkinsonjack livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs AT hineslindseya livingundercoronavirusandinjectingdrugsinbristollucidbaqualitativestudyofexperiencesofcovid19amongpeoplewhoinjectdrugs |